Onglyza Heart Failure Lawsuit

Quite often, new prescription medications are hurried to the marketplace without appropriate assessments and evaluations of the severity and risks of likely side-effects.

The latest medication to capture the attention of the U.S. Food & Drug Administration after recent research have disclosed a possible association between the use and an increase of potential heart failure and developing pancreatic cancer is Onglyza.

If there’s any credence with additional studies administered by the U.S. Food & Drug Administration in allegations, the manufacturer of Onglyza, AstraZeneca, may he held liable to individuals who have taken Onglyza, and sustained heart disease or developed cancers due to the medication.

In an Onglyza heart failure lawsuit, attorneys commit to hold liable the manufacturers of the medication resulting in harm.

Attorneys review these heart failure lawsuits related to Onglyza across the nation, and are willing to discuss your case and potential entitlement to compensation.

Insulin is purported to move glucose into the cells from the blood; type-2 diabetics usually suffer from insulin resistance and inhibited production of insulin combined.

Onglyza is prescription medication for treating type-2 diabetes and enables lowering blood sugar by a prompt of releasing insulin via the pancreas to limit by the liver production of glucose.

By an increase of insulin levels, additional glucose flows to the cells that require it, and forces the liver to hold reserves of glucose to ensure that the body will use additional released glucose into the bloodstream after meals, thus, at lower levels sustaining blood glucose.

The prime advantage for the Onglyza prescription is that, unlike other medications for diabetes, it does not result in retention or weight gain.

The FDA approved AstraZeneca for the market nearly a decade ago. While the medication has proven to improve in patients levels of blood glucose, other individuals argue that the manufacturer has withheld vital information related to deleterious side-effects and connects to severe or life-threatening conditions.

A research study was published in the New England Journal of Medicine to prompt the U.S. Food & Drug Administration to issue an alert of safety, and begin an investigation into whether the prescription is associated with side-effects which had not been disclosed previously.

In an Onglyza heart failure lawsuit, product liability law enables individuals injured due to the use of the product to hold liable the manufacturer for sustained injuries which have happened when the product, as instructed, is used.

If you were prescribed the Onglyza medication for treating diabetes, and endured critical side-effects such as heart failure, cardiovascular disease, developing pancreatic cancer or tumors, then you may be able to recover damages for the cost of suffering and pain, medical care, and any compensatory loss forced upon you to incur, presently and subsequently.

You will know exactly what is expected of you throughout the litigation process, and the potential value of your legal case if you decide to file an Onglyza heart failure lawsuit.

Contact us for a free consultation or call Anzalone Law Firm PLLC, at: 603.548.3797.